Biodesix Inc at Morgan Stanley Global Healthcare Conference Transcript
Hi. My name is Yuko Oku, and I'm on the life science tools and diagnostics team here at MS. Before we begin, I would like to remind our listeners that important disclosure information can be found at morganstanley.com/researchdisclosures. It's my pleasure to host Biodesix. And on behalf of the company, the CEO, Scott Hutton, thank you for joining us today.
Yeah, thank you.
Questions & Answers
Maybe to start, could you begin by highlighting some of Biodesix's key accomplishments this year and what you're most excited about as we head into '23?
Yeah, it's a great question. 2022 has been a big year for us as we come out of COVID. Physicians returning to practice was key for us, right, focusing on the pulmonology call point. We know pulmonologists
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
